https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34534 Tue 26 Mar 2019 12:02:33 AEDT ]]> Work-related asthma: a position paper from the thoracic society of Australia and New Zealand and the national asthma council Australia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40361 Thu 14 Jul 2022 08:03:43 AEST ]]>